Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
cb-010 save search
Insuring Cyber Health | Chubb’s Insight via SentinelOne Telemetry
Published: 2024-04-17 (Crawled : 14:00) - sentinelone.com
CB | $250.005 1.88% 650K
|
Finance
|
| O: -0.73%
H: 0.0%
C: 0.0%
health
PureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
PTCHF | $2.78 19.97% 560
|
n/a
| Email alert
Add to watchlist
lyt-100 fibrosis trial
Combined Insurance Continues Legacy of Military Support
Published: 2024-04-15 (Crawled : 17:00) - prnewswire.com
CB | $250.005 1.88% 650K
|
Finance
|
| O: 1.44%
H: 0.02%
C: -1.97%
insurance military
Galectin Therapeutics Reports the Positive Outcome of the Fifth Data and Safety Monitoring Board Meeting for NAVIGATE Phase 2b/3 Study of Belapectin in Patients with Cirrhotic Portal Hypertension Caused by Metabolic Dysfunction-Associated SteatoHepatitis
Published: 2024-04-09 (Crawled : 12:00) - globenewswire.com
GALT | $3.25 -3.85% 120K
|
Health Technology
|
| O: 2.19%
H: 6.15%
C: 5.35%
metabolic positive for meeting hypertension therapeutics study
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
Published: 2024-04-04 (Crawled : 20:00) - globenewswire.com
CRBU | $3.88 -0.77% 650K
|
Health Technology
|
| O: 1.32%
H: 1.41%
C: -2.17%
cb-010 fda lupus clearance
Parsons Awarded Position on $1B NNSA Counter Nuclear Smuggling System Deployment Contract
Published: 2024-04-03 (Crawled : 20:00) - globenewswire.com
PSN | News | $77.3 -0.64% 130K
|
Technology Services
|
| O: 1.09%
H: 0.55%
C: -0.38%
nuclear contract system
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
Published: 2024-04-01 (Crawled : 19:00) - biospace.com/
EQ | $1.715 -0.87% 62K
|
Health Technology
|
| O: -1.73%
H: 0.0%
C: -7.05%
lupus positive topline study
Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
OCEA | $1.82 -2.93% 150K
|
|
| O: 0.49%
H: 0.0%
C: -7.23%
global immunotherapy
Promising First-In-Human Phase 1B Clinical Study Data from VRON-0200, a Novel, First-in-Class Checkpoint Modifier Immunotherapy for Chronic Hepatitis B Virus Functional Cure, Presented as Late-Breaker at 2024 APASL Global Liver Meeting
Published: 2024-03-28 (Crawled : 00:00) - prnewswire.com
OCEA | $1.82 -2.93% 150K
|
|
| O: 0.49%
H: 0.0%
C: -7.23%
vron-0200 hepatitis liver global immunotherapy meeting virus study
Chubb Launches New Platform to Give Agents Quicker Access to Flood Quotes
Published: 2024-03-27 (Crawled : 13:00) - prnewswire.com
CB | $250.005 1.88% 650K
|
Finance
|
| O: 0.35%
H: 0.63%
C: 0.59%
platform
Moleculin Announces Positive Interim Data in Annamycin MB-106 Phase 1B/2 AML Trial
Published: 2024-03-25 (Crawled : 14:00) - biospace.com/
MBRX | News | $4.5235 2.9K
|
Health Technology
|
| O: 5.18%
H: 0.0%
C: -12.5%
mb-106 positive aml trial
STIFEL TO ACQUIRE FINANCE 500 and CB RESOURCE
Published: 2024-03-14 (Crawled : 13:00) - globenewswire.com
SF | News G | $75.2 0.43% 150K
|
Finance
|
| O: -0.17%
H: 0.0%
C: -1.72%
acquire 500
Parsons Wins Position on $1B Contract Supporting DC Metro Projects
Published: 2024-03-13 (Crawled : 15:30) - parsons.com
PSN | News | $77.3 -0.64% 130K
|
Technology Services
|
| O: -0.38%
H: 2.19%
C: 2.03%
contract
Global Classic Car Insurance Market Report 2024: Gross Written Premiums to Reach $51.91 Billion in 2029 - Focus on United States, Canada, Germany, United Kingdom, France, and Italy
Published: 2024-03-13 (Crawled : 01:00) - prnewswire.com
CB | $250.005 1.88% 650K
|
Finance
|
| O: 0.29%
H: 0.81%
C: 0.67%
report reach italy global insurance market
Merck Bets Potential $1B on Pearl Bio’s Genomically Recoded Organisms
Published: 2024-03-12 (Crawled : 17:00) - biospace.com/
JNJ | News | $147.17 0.98% 3.2M
|
Health Technology
|
| O: 1.12%
H: 0.0%
C: 0.0%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.01%
H: 0.0%
C: 0.0%
merck potential
Parsons Wins Position on $1B Contract Supporting DC Metro Projects
Published: 2024-03-12 (Crawled : 11:00) - globenewswire.com
PSN | News | $77.3 -0.64% 130K
|
Technology Services
|
| O: 0.47%
H: 0.76%
C: 0.51%
contract
Press Release: New Phase 2b results for amlitelimab support potential for best-in-class maintenance of response in atopic dermatitis
Published: 2024-03-11 (Crawled : 06:00) - globenewswire.com
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
dermatitis response potential results
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 22:00) - globenewswire.com
CRBU | $3.88 -0.77% 650K
|
Health Technology
|
| O: 1.63%
H: 0.54%
C: -0.67%
cb-012 association cancer cell research preclinical meeting car-t
Chubb Limited Announces Pricing of $1 Billion Senior Notes Offering by Subsidiary
Published: 2024-03-05 (Crawled : 02:00) - prnewswire.com
CB | $250.005 1.88% 650K
|
Finance
|
| O: -0.0%
H: 0.67%
C: 0.45%
offering
Trade Credit Insurance Global Market Report 2024: A Projected $17.48 Billion Market in 2028, Registering a Compound Annual Growth Rate of 9.3%
Published: 2024-03-04 (Crawled : 19:00) - prnewswire.com
WTW M | $264.315 0.5% 120K
|
Finance and Insurance
|
| O: -0.03%
H: 0.21%
C: -0.11%
MKL | $1450.94 1.03% 14K
|
Finance
|
| O: 0.04%
H: 0.98%
C: -0.56%
CNA | $44.33 2.28% 75K
|
Finance
|
| O: 0.12%
H: 1.87%
C: 0.94%
CB | $250.005 1.88% 650K
|
Finance
|
| O: -0.0%
H: 0.67%
C: 0.45%
AON | $309.98 0.42% 220K
|
Finance
|
| O: -0.31%
H: 0.48%
C: 0.05%
report global insurance growth market
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.